Trevi Therapeutics Inc (TRVI)

Stock-Based Compensation

$3.27M

Quarterly · Period ending: · USD

TRVI logo

TRVI Stock-Based Compensation

Latest reported$3.27M
TRVI Quarterly Stock-Based Comp ($60.00 → $3.27M)
High-resolution chart · PNG

TRVI stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Trevi Therapeutics Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
3,272,000
2,191,000
1,350,000
1,243,000
1,384,000
1,208,000
917,000
821,000
1,127,000
723,000
534,000
530,000
605,000
578,000
501,000
569,000
520,000
737,000
540,000
540,000
745,000
718,000
510,000
588,000
589,000
730,000
373,000
371,000
237,000
146,000
185,000
121,000
102,000
88,000
60
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.